Shanghai Fosun Pharmaceutical (Group) Co., Ltd. (SFOSF)

SFOSF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Oct 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	10,113	8,186	8,686	12,603	17,924	19,268
Market Cap Growth	35.05%	-5.76%	-31.08%	-29.69%	-6.98%	106.13%
Enterprise Value	14,893	12,438	12,583	15,964	21,251	22,626
Last Close Price	3.30	1.80	2.19	3.21	4.38	4.66
PE Ratio	22.31	21.57	25.82	23.30	24.08	34.34
PS Ratio	1.81	1.46	1.49	1.98	2.92	4.15
PB Ratio	1.20	1.00	1.09	1.61	2.35	2.74
P/TBV Ratio	3.26	2.73	2.89	3.99	5.83	6.40
P/FCF Ratio	231.28	894.58	-	-	-	-
P/OCF Ratio	15.40	13.35	18.04	20.61	28.92	48.76
EV/Sales Ratio	2.65	2.21	2.15	2.51	3.46	4.87
EV/EBITDA Ratio	18.78	16.47	22.98	19.87	32.27	36.18
EV/EBIT Ratio	41.36	30.53	75.34	32.19	53.22	56.42
EV/FCF Ratio	340.60	1359.25	-	-	-	-
Debt / Equity Ratio	0.61	0.60	0.62	0.56	0.53	0.52
Debt / EBITDA Ratio	6.51	6.07	8.44	5.25	5.86	5.63
Debt / FCF Ratio	117.44	539.31	-	-	-	-
Asset Turnover	0.34	0.36	0.38	0.44	0.44	0.38
Inventory Turnover	2.96	2.90	3.01	3.77	3.82	3.03
Quick Ratio	0.71	0.68	0.73	0.78	0.75	0.71
Current Ratio	0.95	0.92	1.00	1.06	1.04	1.01
Return on Equity (ROE)	6.82%	6.03%	5.23%	7.70%	10.55%	9.25%
Return on Assets (ROA)	1.37%	1.61%	0.67%	2.13%	1.79%	2.05%
Return on Capital (ROIC)	1.68%	1.98%	0.84%	2.70%	2.21%	2.50%
Return on Capital Employed (ROCE)	3.10%	3.70%	1.50%	4.60%	4.00%	4.50%
Earnings Yield	4.48%	4.64%	3.87%	4.29%	4.15%	2.91%
FCF Yield	0.43%	0.11%	-3.12%	-1.92%	-0.91%	-1.48%
Dividend Yield	-	2.44%	1.74%	1.89%	2.02%	1.41%
Payout Ratio	65.25%	74.35%	102.89%	63.64%	40.48%	50.09%
Buyback Yield / Dilution	-0.09%	-0.02%	-2.40%	-1.74%	-	-
Total Shareholder Return	-0.09%	2.42%	-0.66%	0.16%	2.02%	1.41%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.